Does Maroteaux-Lamy Syndrome have a cure?

Currently, there is no curative treatment for Maroteaux-Lamy Syndrome (Mucopolysaccharidosis type VI). While the condition is progressive and life-long, current medical interventions focus on managing symptoms and slowing disease progression through enzyme replacement therapy and supportive care.

What treatments are available for Maroteaux-Lamy Syndrome?

Management for Maroteaux-Lamy Syndrome is multidisciplinary. The gold standard treatment is Enzyme Replacement Therapy (ERT) using recombinant human arylsulfatase B (galsulfase). While ERT does not cure the underlying genetic defect, it significantly improves respiratory function, joint mobility, and endurance in patients with Maroteaux-Lamy Syndrome. Hematopoietic stem cell transplantation (HSCT) is also considered in specific cases, primarily for children with a rapidly progressing phenotype, to provide a source of the missing enzyme.

What research is being conducted to find a cure?

The scientific community is aggressively investigating therapies that address the root cause of Maroteaux-Lamy Syndrome. Current research focuses on:

• Gene Therapy: Developing viral vectors to deliver a functional copy of the ARSB gene to cells.


• Substrate Reduction Therapy: Small molecule drugs designed to inhibit the production of the glycosaminoglycans (GAGs) that accumulate in Maroteaux-Lamy Syndrome.


• Next-Generation ERT: Engineering enzymes that can better cross the blood-brain barrier to address neurological manifestations.

How can patients stay informed about clinical trials?

The landscape for Maroteaux-Lamy Syndrome is evolving rapidly. Patients and families can track active studies through the following resources:

1. ClinicalTrials.gov: Search for "MPS VI" or "Arylsulfatase B deficiency" to find current recruitment status.


2. National MPS Society: Provides curated updates on the latest clinical advancements.


3. DiseaseMaps.org: Connect with our community of 3 members to share experiences regarding clinical trial participation and care coordination.

Next steps

• Consult a metabolic specialist or geneticist to discuss your specific clinical profile.


• Register with patient registries to ensure you are notified of upcoming clinical trials.


• Join the DiseaseMaps.org community to connect with other families navigating the complexities of Maroteaux-Lamy Syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare provider for clinical decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Mucopolysaccharidosis type VI


• Orphanet: MPS VI (Maroteaux-Lamy syndrome)


• OMIM (Online Mendelian Inheritance in Man): Mucopolysaccharidosis Type VI


• National MPS Society: MPS VI Patient Resources